Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/Development and Use of Risk Minimization Action Plans: Guidance for Industry

Development and Use of Risk Minimization Action Plans: Guidance for Industry

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

March 29, 2005

April 15, 2020

Center for Drug Evaluation and Research

0c2f3726-2538-48fb-815a-44b28e56a090

Related Documents

E2E Pharmacovigilance Planning

Guidance DocumentApril 1, 2005Center for Drug Evaluation and Research
View Details →

Premarketing Risk Assessment: Guidance for Industry

Guidance DocumentMarch 29, 2005Center for Drug Evaluation and Research
View Details →

Q1E Evaluation of Stability Data

Guidance DocumentJune 8, 2004Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.